AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Xenobiotic-Free Culture System To Expand Human Limbal Stem Cells

Technology Benefits: Does not contain xenobiotics: Eliminates risk of transmitting animal disease to recipientDoes not use cholera toxin or DMSO (to enhance membrane permeability)

Technology Application: Transplant of LSCs in patients with limbal stem cell deficiency

Detailed Technology Description: Researchers at UCLA developed a xenobiotic-free manufacturing process to produce transplantable human limbal stem cells for use in treating limbal stem cell deficiency. This method does not require the use of toxic compounds such as cholera toxin (to promote LSC proliferation) or DMSO (to enhance membrane permeability). The researchers have defined an optimal media and growth protocol for these cells.

Others

Background

Limbal stem cell deficiency (LSCD) is a disorder characterized by the loss or dysfunctionality of limbal stem cells (LSCs) and its subsequent ability to regenerate the corneal epithelial surface. LSCD is characterized by persistent epithelial defects, conjunctivalization, neovascularization, scarring, and inflammation, all of which lead to corneal opacity, pain, photophobia, and ultimately blindness. Corneal transplantation is ineffective to treat severe to total LSCD because functional LSCs are not transplanted. The highest success rate of treating LSCD was achieved using single isolated LSCs cultured on 3T3 mouse fibroblasts feeder cells in a culture medium that contained fetal bovine serum (FBS). However, the presence of animal components in such xenobiotic culture systems poses a risk of transmitting animal diseases to human recipients after transplantation. There is a need for an effective and complete xenobiotic free culture system for culturing LSCs that minimizes the risk of cross-contamination and toxic effects when the LSCs are transplanted to the patient.

Related Materials

Mei, Hua, et al. "A three-dimensional culture method to expand limbal stem/progenitor cells". Tissue Engineering Part C: Methods 20.5 (2013): 393-400.
Nakatsu, Martin, et al. "Human limbal mesenchymal cells support the growth of human corneal epithelial stem/progenitor cells". Investigative Ophthalmology & Visual Science, 55.10 (2014): 6953-6959.
GONZALEZ, SHEYLA, et al. "Comparison of Different Limbal Epithelial Stem Cell Isolation Methods to Improve the Epithelial Sheet Quality for Transplantation." Investigative Ophthalmology & Visual Science 54.15 (2013): 989-989.
GONZALEZ, SHEYLA, et al. "Human Bone Marrow-Derived Mesenchymal Stem Cells Support the Growth of Limbal Epithelial Progenitor/Stem Cells". Investigative Ophthalmology & Visual Science 55.13 (2014): 522-522.
GONZALEZ, SHEYLA, et al. "A 3D culture system enhances the ability of human bone marrow stromal cells to support the growth of limbal stem/progenitor cells". Stem Cell Research 16.2 (2016): 358-364.
GONZALEZ, SHEYLA, et al. "Comparative study of xenobiotic-free media for the cultivation of human limbal epithelial stem/progenitor cells". Tissue Engineering Part C: Methods, ahead of print.

Additional Technologies by these Inventors

Tech ID/UC Case

27459/2017-431-0

Related Cases

2017-431-0

*Abstract: UCLA researchers in the Departments of Opthalmology have developed a xenobiotic-free manufacturing process to produce transplantable human limbal stem cells for use in treating limbal stem cell deficiency.

*Principal Investigator: Name: Sophie Deng
Department:

Name: Sheyla Gonzalez
Department:

Country/Region: USA

For more information, please click Here